Clinical trials
Attention Deficit clinical trials
Below are recruiting attention deficit clinical trials, each written for real people, not researchers. We’re tracking 132 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06221358Recruiting
ADHD medication and your genes study
This study looks at how your genes affect your response to Methylphenidate (a common ADHD medication, excluding the quick-release forms). If you live in Western Canada and are starting this treatment, your participation could help doctors personalize ADHD care in the future.
Calgary, AlbertaAges 6–24 - NCT06180681Recruiting
School team program for children with ADHD ages 7-11
This study tests a team-based approach in schools to help children with ADHD. It works with parents, teachers, and school mental health providers to improve the child's behavior and school success.
San Diego, CaliforniaAges 7–11 - NCT05875363Recruiting
Mental health study for youth in the justice system
This study looks at brain development and mental health challenges in young people who have been involved with the police. It aims to understand these issues better so that we can find ways to support them.
TaipeiAges 10–18 - NCT05301361Enrolling by invitationPhase 1
Test of brain testing during stimulant treatment for ADHD
This trial checks whether a “NIH Toolbox” set of child-friendly tests can detect changes when stimulant medicine is used for ADHD. It may help doctors better measure how well stimulant treatment is working in people with intellectual disability.
Sacramento, CaliforniaAges 6–24 - NCT04946253Recruiting
Help in teams to improve care for kids with behavior problems
This study tests a program to help pediatric practice teams work together better, led by clinic leadership and managers, to support children’s behavioral health. Caregivers of children ages 5–12 with behavior problems may also be involved to connect care at home and in the clinic.
Philadelphia, PennsylvaniaAges 18 years+ - NCT04781140RecruitingPhase 4
Viloxazine trial for preschool kids with ADHD
This study tests whether viloxazine extended-release can reduce ADHD symptoms in children ages 4–5. It also checks safety in preschool-age kids, including heart and nervous-system side effects.
Saraland, AlabamaAges 4 years–5.8 years - NCT04631042Recruiting
Study how the brain relates to impulsivity and compulsivity
This study looks at how brain function and structure relate to impulsive and compulsive behaviors. It may help researchers understand what drives these behaviors and who may benefit from future mental health treatments.
Bethesda, MarylandAges 6–80 - NCT04278404Recruiting
Drug safety study for children already on certain medicines
This study measures how certain medicines move through the body and checks their safety in children. It may help doctors better understand dosing and side effects in kids who are already receiving these treatments, or in some kids who recently tested positive for COVID-19.
Phoenix, ArizonaAges birth–20 years - NCT06615115Recruiting
Focus instructions for balance in Parkinson's rehab
This study looks at whether different types of instructions (like focusing on your movements) can help improve balance for people with Parkinson's. It might help you move better and feel more steady.
IstanbulAges 50–70 - NCT07226219RecruitingPhase 1
Medication to help attention in children with sickle cell disease
This study tests whether a common medication called methylphenidate (often used for ADHD) can help children with sickle cell disease who have attention or memory problems. If the child qualifies, the study may offer a new way to improve focus and daily functioning.
Memphis, TennesseeAges 8–17 - NCT06981351Recruiting
Matching addiction treatment to thinking skills in prison
This trial tests whether matching treatment to specific thinking and learning problems can help people in prison who have struggled with drugs or alcohol. If you join, you may get a program designed just for your needs.
Albuquerque, New MexicoAges 18–55 - NCT06501495Recruiting
Brain waves and memory in aging and Alzheimer's
This study looks at how brain waves (EEG) change during normal aging and early Alzheimer's disease. It compares three groups: people with early-stage Alzheimer's, healthy older adults, and healthy young adults. The goal is to understand how memory and thinking problems relate to slow brain wave activity.
ParisAges 18–85
Hear when a new Attention Deficit trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for attention deficit?
- Yes. Clin2 currently lists 132 recruiting attention deficit studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a attention deficit trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a attention deficit trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.